Increased expression of the pro-apoptotic Bcl2 family member PUMA is required for mitochondrial release of cytochrome C and the apoptosis associated with skeletal myoblast differentiation

Apoptosis

Volumn 12, Issue 12, 2007, Pages 2143-2154

  Shaltouki, Atossa ^a   Freer, Margot ^b   Mei, Yu ^a   Weyman, Crystal M ^a  

^a CLEVELAND STATE UNIVERSITY   (United States)

^b KENT STATE UNIVERSITY   (United States)

Author keywords

Apoptosis; PUMA; Skeletal myoblast

Indexed keywords

CASPASE 9; CYTOCHROME C; PROTEIN BCL 2; PROTEIN P53; PUMA PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CYTOSOL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MITOCHONDRION; MYOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; APOPTOSIS; BENZOTHIAZOLES; CASPASE 3; CASPASE 9; CELL DIFFERENTIATION; CULTURE MEDIA; CYTOCHROMES C; DNA FRAGMENTATION; ENZYME ACTIVATION; MICE; MITOCHONDRIA; MYOBLASTS, SKELETAL; PROTEIN BIOSYNTHESIS; PROTO-ONCOGENE PROTEINS C-BCL-2; TOLUENE; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 35948969153     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-007-0135-z     Document Type: Article

References (62)

1. Sandri MC, Massimino M, Geromel ML, Arslan P (1996) Myoblasts and myotubes in primary cultures deprived of growth factors undergo apoptosis. Basic Appl. Myol. 6:257-260
2. Chinni C, de Niese MR, Tew DJ, Jenkins AL, Bottomley SP, Mackie EJ (1999) Thrombin, a survival factor for cultured myoblasts. J Biol Chem 274:9169-9174
3. Wang J, Walsh K (1996) Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science 273:359-361
4. Dee K, Freer M, Mei Y, Weyman CM (2002) Apoptosis coincident with the differentiation of skeletal myoblasts is delayed by caspase 3 inhibition and abrogated by MEK-independent constitutive Ras signaling. Cell Death Differ 9:209-218
5. Mampuru LJ, Chen SJ, Kalenik JL, Bradley ME, Lee TC (1996) Analysis of events associated with serum deprivation-induced apoptosis in C3H/Sol8 muscle satellite cells. Exp Cell Res 226:372-380
6. Miller JB, Stockdale FE (1986) Developmental regulation of the multiple myogenic cell lineages of the avian embryo. J Cell Biol 103:2197-2208
7. Fidzianska A, Goebel HH (1991) Human ontogenesis. 3. Cell death in fetal muscle. Acta Neuropathol (Berl) 81:572-577
8. Sandri M, Carraro U (1999) Apoptosis of skeletal muscles during development and disease. Int J Biochem Cell Biol 31:1373-1390
9. Sandri M, El Meslemani AH, Sandri C et al (2001) Caspase 3 expression correlates with skeletal muscle apoptosis in Duchenne and facioscapulo human muscular dystrophy. A potential target for pharmacological treatment? J Neuropathol Exp Neurol 60:302-312
10. Skuk D, Tremblay JP (2003) Cell therapies for inherited myopathies. Curr Opin Rheumatol 15:723-729
11. Skuk D, Tremblay JP (2003) Myoblast transplantation: the current status of a potential therapeutic tool for myopathies. J Muscle Res Cell Motil 24:285-300
12. Skuk D, Caron NJ, Goulet M, Roy B, Tremblay JP (2003) Resetting the problem of cell death following muscle-derived cell transplantation: detection, dynamics and mechanisms. J Neuropathol Exp Neurol 62:951-967
13. Menasche P (2004) Myoblast transfer in heart failure. Surg Clin North Am 84:125-139
14. Menasche P (2004) Skeletal myoblast transplantation for cardiac repair. Expert Rev Cardiovasc Ther 2:21-28
15. Ciammola A, Sassone J, Alberti L et al (2006) Increased apoptosis, Huntingtin inclusions and altered differentiation in muscle cell cultures from Huntington's disease subjects. Cell Death Differ 13:2068-2078
16. Du J, Wang X, Miereles C et al (2004) Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions. J Clin Invest 113:115-123
17. Wang J, Guo K, Wills KN, Walsh K (1997) Rb functions to inhibit apoptosis during myocyte differentiation. Cancer Res 57:351-354
18. Nakanishi K, Sudo T, Morishima N (2005) Endoplasmic reticulum stress signaling transmitted by ATF6 mediates apoptosis during muscle development. J Cell Biol 169:555-560
19. Cerone MA, Marchetti A, Bossi G, Blandino G, Sacchi A, Soddu S (2000) p53 is involved in the differentiation but not in the differentiation-associated apoptosis of myoblasts. Cell Death Differ 7:506-508
20. O'Flaherty J, Mei Y, Freer M, Weyman CM (2006) Signaling through the TRAIL receptor DR5/FADD pathway plays a role in the apoptosis associated with skeletal myoblast differentiation. Apoptosis 11:2103-2113
21. Karasarides M, Dee K, Schulman D, Wolfman A, Weyman CM (2006) Active Ras-induced effects on skeletal myoblast differentiation and apoptosis are independent of constitutive PI3-kinase activity. Cell Biol Int 30:308-318
22. Dee K, DeChant A, Weyman CM (2003) Differential signaling through NFkappaB does not ameliorate skeletal myoblast apoptosis during differentiation. FEBS Lett 545:246-252
23. DeChant AK, Dee K, Weyman CM (2002) Raf-induced effects on the differentiation and apoptosis of skeletal myoblasts are determined by the level of Raf signaling: abrogation of apoptosis by Raf is downstream of caspase 3 activation. Oncogene 21:5268-5279
24. Mercer SE, Ewton DZ, Deng X, Lim S, Mazur TR, Friedman E (2005) Mirk/Dyrk1B mediates survival during the differentiation of C2C12 myoblasts. J Biol Chem 280:25788-25801
25. Kuwana T, Newmeyer DD (2003) Bcl-2-family proteins and the role of mitochondria in apoptosis. Curr Opin Cell Biol 15:691-699
26. Scorrano L, Korsmeyer SJ (2003) Mechanisms of cytochrome c release by proapoptotic BCL-2 family members. Biochem Biophys Res Commun 304:437-444
27. Puthalakath H, Strasser A (2002) Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins. Cell Death Differ 9:505-512
28. Weyman CM, Ramocki MB, Taparowsky EJ, Wolfman A (1997) Distinct signaling pathways regulate transformation and inhibition of skeletal muscle differentiation by oncogenic Ras. Oncogene 14:697-704
29. Weyman CM, Wolfman A (1998) Mitogen-activated protein kinase kinase (MEK) activity is required for inhibition of skeletal muscle differentiation by insulin-like growth factor 1 or fibroblast growth factor 2. Endocrinology 139:1794-1800
30. Weyman CM, Wolfman A (1997) Oncogenic Ras-induced secretion of a novel inhibitor of skeletal myoblast differentiation. Oncogene 15:2521-2528
31. Vaidya TB, Weyman CM, Teegarden D, Ashendel CL, Taparowsky EJ (1991) Inhibition of myogenesis by the H-ras oncogene: implication of a role for protein kinase C. J Cell Biol 114:809-820
32. Konieczny SF, Emerson CP Jr 1984 5-Azacytidine induction of stable mesodermal stem cell lineages from 10T1/2 cells: evidence for regulatory genes controlling determination. Cell 38:791-800
33. Thornberry NA, Lazebnik Y (1998) Caspases: enemies within. Science 281:1312-1316
34. Orrenius S (2004) Mitochondrial regulation of apoptotic cell death. Toxicol Lett 149:19-23
35. Nakano K, Vousden KH (2001) PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 7:683-694
36. Yu J, Zhang L, Hwang PM, Kinzler KW, Vogelstein B (2001) PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell 7:673-682
37. Han J, Flemington C, Houghton AB et al (2001) Expression of bbc3, a pro-apoptotic BH3-only gene, is regulated by diverse cell death and survival signals. Proc Natl Acad Sci U S A 98:11318-11323
38. Komarov PG, Komarova EA, Kondratov RV et al (1999) A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285:1733-1737
39. Porrello A, Cerone MA, Coen S et al (2000) p53 regulates myogenesis by triggering the differentiation activity of pRb. J Cell Biol 151:1295-1304
40. Zeuner A, Eramo A, Peschle C, De Maria R (1999) Caspase activation without death. Cell Death Differ 6:1075-1080
41. Schwerk C, Schulze-Osthoff K (2003) Non-apoptotic functions of caspases in cellular proliferation and differentiation. Biochem Pharmacol 66:1453-1458
42. Dominov JA, Dunn JJ, Miller JB (1998) Bcl-2 expression identifies an early stage of myogenesis and promotes clonal expansion of muscle cells. J Cell Biol 142:537-544
43. Melino G, De Laurenzi V, Vousden KH (2002) p73: Friend or foe in tumorigenesis. Nat Rev Cancer 2:605-615
44. Melino G, Bernassola F, Ranalli M et al (2004) p73 Induces apoptosis via PUMA transactivation and Bax mitochondrial translocation. J Biol Chem 279:8076-8083
45. Belloni L, Moretti F, Merlo P et al (2006) DNp73alpha protects myogenic cells from apoptosis. Oncogene 25:3606-3612
46. Li CY, Zhu J, Wang JY (2005) Ectopic expression of p73alpha, but not p73beta, suppresses myogenic differentiation. J Biol Chem 280:2159-2164
47. Olson EN (1992) Interplay between proliferation and differentiation within the myogenic lineage. Dev Biol 154:261-272
48. Fujio Y, Guo K, Mano T, Mitsuuchi Y, Testa JR, Walsh K (1999) Cell cycle withdrawal promotes myogenic induction of Akt, a positive modulator of myocyte survival. Mol Cell Biol 19:5073-5082
49. Lawlor MA, Rotwein P (2000) Insulin-like growth factor-mediated muscle cell survival: central roles for Akt and cyclin-dependent kinase inhibitor p21. Mol Cell Biol 20:8983-8995
50. Martinez-Gac L, Alvarez B, Garcia Z, Marques M, Arrizabalaga M, Carrera AC (2004) Phosphoinositide 3-kinase and Forkhead, a switch for cell division. Biochem Soc Trans 32:360-361
51. Gilley J, Coffer PJ, Ham J (2003) FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons. J Cell Biol 162:613-622
52. Wang Q, Wang X, Hernandez A, Hellmich MR, Gatalica Z, Evers BM (2002) Regulation of TRAIL expression by the phosphatidylinositol 3-kinase/Akt/GSK-3 pathway in human colon cancer cells. J Biol Chem 277:36602-36610
53. Zhao R, Gish K, Murphy M et al (2000) Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev 14:981-993
54. Erlacher M, Labi V, Manzl C et al (2006) Puma cooperates with Bim, the rate-limiting BH3-only protein in cell death during lymphocyte development, in apoptosis induction. J Exp Med 203:2939-2951
55. Bauer A, Villunger A, Labi V et al (2006) The NF-kappaB regulator Bcl-3 and the BH3-only proteins Bim and Puma control the death of activated T cells. Proc Natl Acad Sci U S A 103:10979-10984
56. Fernando P, Kelly JF, Balazsi K, Slack RS, Megeney LA (2002) Caspase 3 activity is required for skeletal muscle differentiation. Proc Natl Acad Sci U S A 99:11025-11030
57. Jeffers JR, Parganas E, Lee Y et al (2003) Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 4:321-328
58. Raff MC (1992) Social controls on cell survival and cell death. Nature 356:397-400
59. Bouchentouf M, Benabdallah BF, Tremblay JP (2004) Myoblast survival enhancement and transplantation success improvement by heat-shock treatment in mdx mice. Transplantation 77:1349-1356
60. Busquets S, Deans C, Figueras M et al (2007) Apoptosis is present in skeletal muscle of cachectic gastro-intestinal cancer patients. Clin Nutr (e-pub) PMID: 1768894
61. Adhihetty PJ, Taivassalo T, Haller RG, Walkinshaw DR, Hood DA (2007) The effect of training on the expression of mitochondrial biogenesis- and apoptosis-related proteins in skeletal muscle of patients with mtDNA defects. Am J Physiol Endocrinol Metab (e-pub) PMID: 17551003
62. Mitch WE, Hu Z, Lee SW, Du J (2005) Strategies for suppressing muscle atrophy in chronic kidney disease: mechanisms activating distinct proteolytic systems. J Ren Nutr 15:23-27